Bayer AG
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference e73d644d0f
Drug names50First applicant · distinct drug namesAcceptance records244First applicant · distinct acceptance numbersUnder-review numbers21First applicant · current under-review listCo-applicant records139Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
244 acceptance records as first applicant, grouped into 50 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Nifedipine Controlled-release Tablets 9 records · Latest accepted 2026/11/03
Import re-registration · 4Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600289 | Import re-registration | 2026/11/03 | Bayer AG; Name not romanized | CDE ↗ |
| JYHZ2600288 | Import re-registration | 2026/11/03 | Bayer AG; Name not romanized | CDE ↗ |
| JYHB2600349 | Supplement | 2026/06/26 | Bayer AG | CDE ↗ |
| JYHB2600348 | Supplement | 2026/06/26 | Bayer AG | CDE ↗ |
| JYHB2600155 | Supplement | 2026/03/10 | Bayer AG | CDE ↗ |
| JYHB2200563 | Supplement | 2022/10/15 | Bayer AG | CDE ↗ |
| JYHB2200562 | Supplement | 2022/10/15 | Bayer AG | CDE ↗ |
| JYHZ2200092 | Import re-registration | 2022/03/24 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2200091 | Import re-registration | 2022/03/24 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
Regorafenib Tablets 7 records · Latest accepted 2026/10/27
Supplement · 5Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600576 | Supplement | 2026/10/27 | Bayer AG | CDE ↗ |
| JYHB2600553 | Supplement | 2026/10/16 | Bayer AG; Patheon Pharmaceuticals Inc. | CDE ↗ |
| JYHB2500639 | Supplement | 2025/11/24 | Bayer AG | CDE ↗ |
| JYHZ2500120 | Import re-registration | 2025/06/25 | Bayer AG | CDE ↗ |
| JYHB2300319 | Supplement | 2023/05/31 | Bayer AG | CDE ↗ |
| JYHB2101052 | Supplement | 2021/04/21 | Bayer AG | CDE ↗ |
| JYHZ2100068 | Import re-registration | 2021/04/01 | Bayer AG | CDE ↗ |
No verified English name 21 records · Latest accepted 2026/10/09
Supplement · 18Import re-registration · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600542 | Supplement | 2026/10/09 | Bayer AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHB2600541 | Supplement | 2026/10/09 | Bayer AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHB2600540 | Supplement | 2026/10/09 | Bayer AG; Delpharm Milano S.r.l. | CDE ↗ |
| JYHZ2600129 | Import re-registration | 2026/05/19 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600128 | Import re-registration | 2026/05/19 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600127 | Import re-registration | 2026/05/19 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHB2600255 | Supplement | 2026/05/09 | Bayer AG | CDE ↗ |
| JYHB2600254 | Supplement | 2026/05/09 | Bayer AG | CDE ↗ |
| JYHB2600253 | Supplement | 2026/05/09 | Bayer AG | CDE ↗ |
| JYHB2500123 | Supplement | 2025/03/10 | Bayer AG | CDE ↗ |
| JYHB2500122 | Supplement | 2025/03/10 | Bayer AG | CDE ↗ |
| JYHB2500120 | Supplement | 2025/03/10 | Bayer AG | CDE ↗ |
| JYHB2400569 | Supplement | 2024/10/23 | Bayer AG | CDE ↗ |
| JYHB2400568 | Supplement | 2024/10/23 | Bayer AG | CDE ↗ |
| JYHB2400567 | Supplement | 2024/10/23 | Bayer AG | CDE ↗ |
| JYHB2300606 | Supplement | 2023/10/25 | Bayer AG | CDE ↗ |
| JYHB2300605 | Supplement | 2023/10/25 | Bayer AG | CDE ↗ |
| JYHB2300604 | Supplement | 2023/10/25 | Bayer AG | CDE ↗ |
| JYHB2200386 | Supplement | 2022/07/25 | Bayer AG | CDE ↗ |
| JYHB2200385 | Supplement | 2022/07/25 | Bayer AG | CDE ↗ |
| JYHB2200384 | Supplement | 2022/07/25 | Bayer AG | CDE ↗ |
No verified English name 19 records · Latest accepted 2026/08/13
Import · 3Supplement · 14Not stated by source · 1Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600073 | Import | 2026/08/13 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYSB2600220 | Supplement | 2026/08/05 | Bayer AG | CDE ↗ |
| JYSB2600025 | Supplement | 2026/01/31 | Bayer AG; Catalent Indiana LLC | CDE ↗ |
| JTS2600009 | Not stated by source | 2026/01/23 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JYSB2500276 | Supplement | 2025/12/02 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JYSB2500266 | Supplement | 2025/11/13 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JYSB2500265 | Supplement | 2025/11/13 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JYSB2500169 | Supplement | 2025/07/18 | Bayer AG; Catalent Indiana LLC | CDE ↗ |
| JYSB2400164 | Supplement | 2024/07/24 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JYSB2400163 | Supplement | 2024/07/24 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JYSB2400027 | Supplement | 2024/02/05 | Bayer AG; Catalent Indiana LLC | CDE ↗ |
| JYSB2400011 | Supplement | 2024/01/23 | Bayer AG; Catalent Indiana LLC | CDE ↗ |
| JXSS2300092 | Import | 2023/12/15 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co. KG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXSL2300080 | Import | 2023/04/26 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXSB2300013 | Supplement | 2023/01/13 | Bayer AG; Baxter Pharmaceutical Solutions LLC; Catalent Indiana LLC | CDE ↗ |
| JYSB2200220 | Supplement | 2022/12/07 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JYSB2200198 | Supplement | 2022/10/12 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JYSZ2200053 | Import re-registration | 2022/10/11 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co. KG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYSB2100092 | Supplement | 2021/04/07 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
Finerenone Tablets 23 records · Latest accepted 2026/08/13
Import · 11Import re-registration · 2Supplement · 9Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2600089 | Import | 2026/08/13 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHS2600088 | Import | 2026/08/13 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600161 | Import re-registration | 2026/07/06 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600160 | Import re-registration | 2026/07/06 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHB2500070 | Supplement | 2025/06/10 | Bayer AG | CDE ↗ |
| JXHB2500069 | Supplement | 2025/06/10 | Bayer AG | CDE ↗ |
| JXHS2500017 | Import | 2025/01/24 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHS2500016 | Import | 2025/01/24 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHS2500015 | Import | 2025/01/24 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JTH2400223 | Not stated by source | 2024/12/24 | Bayer AG; Shanghai Di Sai Nuo Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
| JYHB2400363 | Supplement | 2024/07/11 | Bayer AG | CDE ↗ |
| JYHB2400362 | Supplement | 2024/07/11 | Bayer AG | CDE ↗ |
| JXHL2300155 | Import | 2023/07/04 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2300154 | Import | 2023/07/04 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHB2200641 | Supplement | 2022/11/17 | Bayer AG | CDE ↗ |
| JYHB2200640 | Supplement | 2022/11/17 | Bayer AG | CDE ↗ |
| JXHB2200129 | Supplement | 2022/09/08 | Bayer AG | CDE ↗ |
| JXHB2200128 | Supplement | 2022/09/08 | Bayer AG | CDE ↗ |
| JXHB2200127 | Supplement | 2022/09/08 | Bayer AG | CDE ↗ |
| JXHS2200014 | Import | 2022/01/12 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHS2200013 | Import | 2022/01/12 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2101136 | Import | 2021/07/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2101135 | Import | 2021/07/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/20
Import · 2
No verified English name 8 records · Latest accepted 2026/04/30
Import · 4Not stated by source · 1Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2600043 | Import | 2026/04/30 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JTH2500200 | Not stated by source | 2025/12/24 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JXHB2400094 | Supplement | 2024/06/01 | Bayer AG | CDE ↗ |
| JXHB2400035 | Supplement | 2024/02/07 | Bayer AG | CDE ↗ |
| JXHL2300276 | Import | 2023/11/08 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHB2300073 | Supplement | 2023/04/27 | Bayer AG | CDE ↗ |
| JXHL2300002 | Import | 2023/01/07 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2200339 | Import | 2022/11/19 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
Rivaroxaban Tablets 38 records · Latest accepted 2026/04/30
Import re-registration · 9Supplement · 29
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600108 | Import re-registration | 2026/04/30 | Bayer AG; Bayer HealthCare Company Ltd. | CDE ↗ |
| JYHZ2600107 | Import re-registration | 2026/04/30 | Bayer AG; Bayer HealthCare Company Ltd. | CDE ↗ |
| JYHB2500679 | Supplement | 2025/12/10 | Bayer AG | CDE ↗ |
| JYHB2500678 | Supplement | 2025/12/10 | Bayer AG | CDE ↗ |
| JYHB2500677 | Supplement | 2025/12/10 | Bayer AG | CDE ↗ |
| JYHB2500676 | Supplement | 2025/12/10 | Bayer AG | CDE ↗ |
| JYHB2500110 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500109 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500108 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500107 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500106 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500105 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500104 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2500103 | Supplement | 2025/03/04 | Bayer AG; （1）Bayer AG（2）Bayer HealthCare Manufacturing S.r.l. | CDE ↗ |
| JYHB2400656 | Supplement | 2024/12/17 | Bayer AG | CDE ↗ |
| JYHB2400655 | Supplement | 2024/12/17 | Bayer AG | CDE ↗ |
| JYHZ2400220 | Import re-registration | 2024/08/09 | Bayer AG; Bayer Healthcare Company Ltd | CDE ↗ |
| JYHB2400348 | Supplement | 2024/07/08 | Bayer AG | CDE ↗ |
| JYHB2300752 | Supplement | 2023/12/28 | Bayer AG | CDE ↗ |
| JYHB2300751 | Supplement | 2023/12/28 | Bayer AG | CDE ↗ |
| JYHB2300750 | Supplement | 2023/12/28 | Bayer AG | CDE ↗ |
| JYHB2300749 | Supplement | 2023/12/28 | Bayer AG | CDE ↗ |
| JYHB2300435 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300434 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300433 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300432 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300431 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300430 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300428 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHB2300425 | Supplement | 2023/07/28 | Bayer AG | CDE ↗ |
| JYHZ2300277 | Import re-registration | 2023/06/29 | Bayer AG; Bayer Healthcare Co. Ltd | CDE ↗ |
| JYHZ2300276 | Import re-registration | 2023/06/29 | Bayer AG; Bayer Healthcare Co. Ltd | CDE ↗ |
| JYHZ2300275 | Import re-registration | 2023/06/29 | Bayer AG; Bayer Healthcare Co. Ltd | CDE ↗ |
| JYHZ2300274 | Import re-registration | 2023/06/29 | Bayer AG; Bayer Healthcare Co. Ltd | CDE ↗ |
| JYHB2300187 | Supplement | 2023/03/22 | Bayer AG | CDE ↗ |
| JYHB2300186 | Supplement | 2023/03/22 | Bayer AG | CDE ↗ |
| JYHZ2100730 | Import re-registration | 2021/12/10 | Bayer AG; Bayer Healthcare Co. Ltd | CDE ↗ |
| JYHZ2100729 | Import re-registration | 2021/12/10 | Bayer AG; Bayer Healthcase Co. Ltd | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/04/23
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600225 | Supplement | 2026/04/23 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2500592 | Supplement | 2025/11/06 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2500119 | Supplement | 2025/03/08 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2300658 | Supplement | 2023/11/17 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
No verified English name 10 records · Latest accepted 2026/04/23
Supplement · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600227 | Supplement | 2026/04/23 | Bayer AG; Penn Pharmaceutical Services Limited; NextPharma Plo？rmel SAS. Plo？rmel | CDE ↗ |
| JYHB2600226 | Supplement | 2026/04/23 | Bayer AG; Penn Pharmaceutical Services Limited; NextPharma Plo？rmel SAS. Plo？rmel | CDE ↗ |
| JYHB2500593 | Supplement | 2025/11/06 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2500591 | Supplement | 2025/11/06 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2500300 | Supplement | 2025/06/04 | Bayer AG; Penn Pharmaceutical Services Limited; NextPharma Plo？rmel SAS Plo？rmel | CDE ↗ |
| JYHB2500299 | Supplement | 2025/06/04 | Bayer AG; Penn Pharmaceutical Services Limited; NextPharma Plo？rmel SAS Plo？rmel | CDE ↗ |
| JYHB2500117 | Supplement | 2025/03/08 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2500116 | Supplement | 2025/03/08 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2300660 | Supplement | 2023/11/17 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| JYHB2300659 | Supplement | 2023/11/17 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/04/21
Supplement · 1Import · 1
No verified English name 3 records · Latest accepted 2026/02/26
Not stated by source · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2600045 | Not stated by source | 2026/02/26 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2600044 | Not stated by source | 2026/02/26 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2500188 | Not stated by source | 2025/12/08 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
Riociguat Tablets 15 records · Latest accepted 2026/02/02
Import re-registration · 10Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600016 | Import re-registration | 2026/02/02 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600015 | Import re-registration | 2026/02/02 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600014 | Import re-registration | 2026/02/02 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600013 | Import re-registration | 2026/02/02 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2600012 | Import re-registration | 2026/02/02 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2100643 | Import re-registration | 2021/09/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2100642 | Import re-registration | 2021/09/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2100641 | Import re-registration | 2021/09/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2100640 | Import re-registration | 2021/09/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2100639 | Import re-registration | 2021/09/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHB2101165 | Supplement | 2021/06/17 | Bayer AG | CDE ↗ |
| JYHB2101164 | Supplement | 2021/06/17 | Bayer AG | CDE ↗ |
| JYHB2101163 | Supplement | 2021/06/17 | Bayer AG | CDE ↗ |
| JYHB2101162 | Supplement | 2021/06/17 | Bayer AG | CDE ↗ |
| JYHB2101161 | Supplement | 2021/06/17 | Bayer AG | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/11/11
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2500220 | Import | 2025/11/11 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/09/17
Import · 3Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2500103 | Import | 2025/09/17 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHS2500102 | Import | 2025/09/17 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHS2500101 | Import | 2025/09/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JTH2400121 | Not stated by source | 2024/07/26 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/06
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2500141 | Import | 2025/08/06 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/04/03
Supplement · 5Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500191 | Supplement | 2025/04/03 | Bayer AG; Agilera Pharma AS | CDE ↗ |
| JYHZ2400235 | Import re-registration | 2024/08/31 | Bayer AG; Agilera Pharma AS | CDE ↗ |
| JYHB2400069 | Supplement | 2024/02/05 | Bayer AG; Agilera Pharma AS | CDE ↗ |
| JYHB2400055 | Supplement | 2024/01/31 | Bayer AG; Agilera Pharma AS | CDE ↗ |
| JYHB2200228 | Supplement | 2022/04/24 | Bayer AG; Institute for Energy Technology (IFE) | CDE ↗ |
| JYHB2101333 | Supplement | 2021/08/17 | Bayer AG; Institute for Energy Technology (IFE) | CDE ↗ |
No verified English name 8 records · Latest accepted 2024/11/29
Import · 5Not stated by source · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400275 | Import | 2024/11/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2400274 | Import | 2024/11/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JTH2400196 | Not stated by source | 2024/11/19 | Bayer AG; Bayer HealthCare Pharmaceuticals Inc.; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JXHB2400181 | Supplement | 2024/11/13 | Bayer AG | CDE ↗ |
| JXHL2400140 | Import | 2024/06/15 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHB2200173 | Supplement | 2022/11/15 | Bayer AG | CDE ↗ |
| JXHL2200041 | Import | 2022/02/25 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2200040 | Import | 2022/02/25 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
Sorafenib Tosylate Tablets 3 records · Latest accepted 2024/10/22
Import re-registration · 1Supplement · 2
No verified English name 2 records · Latest accepted 2024/07/09
Import · 2
No verified English name 1 records · Latest accepted 2024/05/10
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2400088 | Import | 2024/05/10 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 7 records · Latest accepted 2024/04/16
Import · 7
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400092 | Import | 2024/04/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2400091 | Import | 2024/04/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2400090 | Import | 2024/04/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2400076 | Import | 2024/03/30 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2400075 | Import | 2024/03/30 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2300271 | Import | 2023/11/03 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2300270 | Import | 2023/11/03 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/04/08
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2400068 | Import | 2024/04/08 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/04/04
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400081 | Import | 2024/04/04 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/02/27
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2400044 | Import | 2024/02/27 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/02/06
Import · 2
No verified English name 3 records · Latest accepted 2023/07/26
Supplement · 2Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2300127 | Supplement | 2023/07/26 | Bayer AG; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYSZ2300021 | Import re-registration | 2023/05/06 | Bayer AG; Boehringer Ingelheim Pharma GmbH & Co. KG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYSB2101062 | Supplement | 2021/06/25 | Bayer AG; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/04/18
Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2300087 | Import | 2023/04/18 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2300086 | Import | 2023/04/18 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2300085 | Import | 2023/04/18 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
Iloprost Solution for Inhalation 3 records · Latest accepted 2022/11/01
Import re-registration · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2200301 | Import re-registration | 2022/11/01 | Bayer AG; BerliMed S.A.; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2200300 | Import re-registration | 2022/11/01 | Bayer AG; BerliMed S.A.; Bayer Healthcare Company Ltd. | CDE ↗ |
| JYHZ2200299 | Import re-registration | 2022/11/01 | Bayer AG; BerliMed S.A.; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/10/20
Supplement · 2
No verified English name 1 records · Latest accepted 2022/09/06
Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200182 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/06
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200178 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2200120 | Not stated by source | 2022/06/28 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/06
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200177 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2200122 | Not stated by source | 2022/06/28 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/06
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200176 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2200119 | Not stated by source | 2022/06/28 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/06
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200179 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2200121 | Not stated by source | 2022/06/28 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/06
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200184 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2200117 | Not stated by source | 2022/06/28 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/09/06
Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200183 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/09/06
Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200181 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/09/06
Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200180 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/06
Not stated by source · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2200175 | Not stated by source | 2022/09/06 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| JTH2200118 | Not stated by source | 2022/06/28 | Bayer AG; Jenapharm GmbH & Co. KG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 4 records · Latest accepted 2021/11/29
Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2101259 | Import | 2021/11/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2101258 | Import | 2021/11/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2101257 | Import | 2021/11/29 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| JXHL2101127 | Import | 2021/07/09 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/10/19
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2101202 | Import | 2021/10/19 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/09/13
Not stated by source · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JTH2100643 | Not stated by source | 2021/09/13 | Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/08/03
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2101148 | Import | 2021/08/03 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/05/20
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2101014 | Import | 2021/05/20 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/05/20
Import · 2
No verified English name 1 records · Latest accepted 2021/03/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2100018 | Supplement | 2021/03/04 | Bayer AG | CDE ↗ |
No verified English name 3 records · Latest accepted 2021/02/25
Supplement · 3
No verified English name 2 records · Latest accepted 2021/02/03
Import · 2
No verified English name 2 records · Latest accepted 2021/01/20
Supplement · 2
Changes in the last 90 days
8 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 7 applicationsNo longer listed under review: 1 application
- 2026/11/03Accepted
Nifedipine Controlled-release Tablets
JYHZ2600289
Fact date: 2026/11/03 · Site observation date: 2026/11/04
View source ↗ - 2026/11/03Accepted
Nifedipine Controlled-release Tablets
JYHZ2600288
Fact date: 2026/11/03 · Site observation date: 2026/11/04
View source ↗ - 2026/10/27Accepted
Regorafenib Tablets
JYHB2600576
Fact date: 2026/10/27 · Site observation date: 2026/10/28
View source ↗ - 2026/10/23No longer listed under review
No verified English name
JXHS2600043
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/04/30
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/16Accepted
Regorafenib Tablets
JYHB2600553
Fact date: 2026/10/16 · Site observation date: 2026/10/22
View source ↗ - 2026/10/09Accepted
No verified English name
JYHB2600542
Fact date: 2026/10/09 · Site observation date: 2026/10/22
View source ↗ - 2026/10/09Accepted
No verified English name
JYHB2600541
Fact date: 2026/10/09 · Site observation date: 2026/10/22
View source ↗ - 2026/10/09Accepted
No verified English name
JYHB2600540
Fact date: 2026/10/09 · Site observation date: 2026/10/22
View source ↗
Under review
21 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Nifedipine Controlled-release Tablets | JYHZ2600289 | Import re-registration | 2026/11/03 | Bayer AG; Name not romanized | CDE ↗ |
| Nifedipine Controlled-release Tablets | JYHZ2600288 | Import re-registration | 2026/11/03 | Bayer AG; Name not romanized | CDE ↗ |
| Regorafenib Tablets | JYHB2600576 | Supplement | 2026/10/27 | Bayer AG | CDE ↗ |
| Regorafenib Tablets | JYHB2600553 | Supplement | 2026/10/16 | Bayer AG; Patheon Pharmaceuticals Inc. | CDE ↗ |
| No verified English name | JYHB2600542 | Supplement | 2026/10/09 | Bayer AG; Delpharm Milano S.r.l. | CDE ↗ |
| No verified English name | JYHB2600541 | Supplement | 2026/10/09 | Bayer AG; Delpharm Milano S.r.l. | CDE ↗ |
| No verified English name | JYHB2600540 | Supplement | 2026/10/09 | Bayer AG; Delpharm Milano S.r.l. | CDE ↗ |
| No verified English name | JXSS2600073 | Import | 2026/08/13 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Finerenone Tablets | JXHS2600089 | Import | 2026/08/13 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Finerenone Tablets | JXHS2600088 | Import | 2026/08/13 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| No verified English name | JYSB2600220 | Supplement | 2026/08/05 | Bayer AG | CDE ↗ |
| Finerenone Tablets | JYHZ2600161 | Import re-registration | 2026/07/06 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Finerenone Tablets | JYHZ2600160 | Import re-registration | 2026/07/06 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| No verified English name | JYHB2600227 | Supplement | 2026/04/23 | Bayer AG; Penn Pharmaceutical Services Limited; NextPharma Plo？rmel SAS. Plo？rmel | CDE ↗ |
| No verified English name | JYHB2600226 | Supplement | 2026/04/23 | Bayer AG; Penn Pharmaceutical Services Limited; NextPharma Plo？rmel SAS. Plo？rmel | CDE ↗ |
| No verified English name | JYHB2600225 | Supplement | 2026/04/23 | Bayer AG; Penn Pharmaceutical Services Limited | CDE ↗ |
| No verified English name | JYSB2600025 | Supplement | 2026/01/31 | Bayer AG; Catalent Indiana LLC | CDE ↗ |
| No verified English name | JYSB2500276 | Supplement | 2025/12/02 | Bayer AG; Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| No verified English name | JXHS2500103 | Import | 2025/09/17 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| No verified English name | JXHS2500102 | Import | 2025/09/17 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| No verified English name | JXHS2500101 | Import | 2025/09/16 | Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
Catalogue holder records
7 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Rivaroxaban Tablets | Bayer AG | Bayer AG | H20150214;H20150216 | 2015/04/29 | Imported originator drug | CDE ↗ |
| Rivaroxaban Tablets | Bayer AG | Bayer AG | H20150213;H20150215 | 2015/04/29 | Imported originator drug | CDE ↗ |
| Rivaroxaban Tablets | Bayer AG | Bayer AG | H20140132;H20140133 | 2009/03/31 | Imported originator drug | CDE ↗ |
| Sorafenib Tosylate Tablets | Bayer AG | Bayer AG | H20160201 | 2006/09/12 | Imported originator drug | CDE ↗ |
| Vardenafil Hydrochloride Tablets | Bayer AG | Bayer AG | H20140495;H20140497 | 2004/08/05 | Imported originator drug | CDE ↗ |
| Finerenone Tablets | Bayer AG | Bayer AG | 国药准字HJ20220057 | 2022/06/28 | Imported originator drug | CDE ↗ |
| Finerenone Tablets | Bayer AG | Bayer AG | 国药准字HJ20220058 | 2022/06/28 | Imported originator drug | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
2 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Bayer AG | Y20250000867 | I | 2025/08/28 | CDE ↗ |
| No verified English name | Bayer AG | Y20170001896 | A | 2025/09/28 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
139 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Gadoxetic Acid Disodium Injection | JYHB2600572 | Supplement | 2026/10/26 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Finerenone Tablets | JTH2600221 | Import | 2026/10/23 | Bayer HealthCare Manufacturing S.r.l.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Finerenone Tablets | JTH2600220 | Import | 2026/10/23 | Bayer HealthCare Manufacturing S.r.l.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Iopromide Injection | JYHZ2600240 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600239 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600238 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600237 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600236 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600235 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600234 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600233 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHZ2600232 | Import re-registration | 2026/09/22 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2600443 | Supplement | 2026/08/06 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2600442 | Supplement | 2026/08/06 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2600441 | Supplement | 2026/08/06 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2600440 | Supplement | 2026/08/06 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2600439 | Supplement | 2026/08/06 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2600438 | Supplement | 2026/08/06 | Bayer Inc.; Bayer AG | CDE ↗ |
| No verified English name | JTS2600121 | Not stated by source | 2026/07/13 | Vetter Pharma-Fertigung GmbH & Co. KG; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Riociguat Tablets | JTH2600136 | Not stated by source | 2026/07/09 | Patheon France; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Riociguat Tablets | JTH2600135 | Not stated by source | 2026/07/09 | Patheon France; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Riociguat Tablets | JTH2600134 | Not stated by source | 2026/07/09 | Patheon France; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Riociguat Tablets | JTH2600133 | Not stated by source | 2026/07/09 | Patheon France; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Riociguat Tablets | JTH2600132 | Not stated by source | 2026/07/09 | Patheon France; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600095 | Not stated by source | 2026/05/26 | Vetter Pharma-Fertigung GmbH & Co. KG; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600094 | Not stated by source | 2026/05/26 | Vetter Pharma-Fertigung GmbH & Co. KG; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JXHS2600038 | Import | 2026/04/13 | Bayer HealthCare Pharmaceuticals Inc.; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHB2600149 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600148 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600147 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600146 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600145 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600144 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600143 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600142 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600141 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600140 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600139 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600138 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600137 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600136 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600135 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2600134 | Supplement | 2026/03/06 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| No verified English name | JTS2600008 | Not stated by source | 2026/01/23 | Regeneron Ireland Designated Activity Company; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Gadobutrol Injection | JYHB2600023 | Supplement | 2026/01/09 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2600022 | Supplement | 2026/01/09 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Finerenone Tablets | JTH2500206 | Not stated by source | 2025/12/29 | Delpharm Milano S.r.l.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Finerenone Tablets | JTH2500205 | Not stated by source | 2025/12/29 | Delpharm Milano S.r.l.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Iopromide Injection | JYHB2500635 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500634 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500633 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500632 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500631 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500630 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500629 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500628 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500627 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500626 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500625 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500624 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500623 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2500622 | Supplement | 2025/11/15 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Regorafenib Tablets | JTH2500154 | Not stated by source | 2025/10/18 | Patheon Pharmaceuticals Inc.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2500131 | Not stated by source | 2025/08/14 | Delpharm Milano S.r.l.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2500130 | Not stated by source | 2025/08/14 | Delpharm Milano S.r.l.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2500129 | Not stated by source | 2025/08/14 | Delpharm Milano S.r.l; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2500176 | Import re-registration | 2025/08/06 | Bayer Inc.; Bayer AG; Name not romanized | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2500175 | Import re-registration | 2025/08/06 | Bayer Inc.; Bayer AG; Name not romanized | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2500174 | Import re-registration | 2025/08/06 | Bayer Inc.; Bayer AG; Name not romanized | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2500173 | Import re-registration | 2025/08/06 | Bayer Inc.; Bayer AG; Name not romanized | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2500172 | Import re-registration | 2025/08/06 | Bayer Inc.; Bayer AG; Name not romanized | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2500171 | Import re-registration | 2025/08/06 | Bayer Inc.; Bayer AG; Name not romanized | CDE ↗ |
| No verified English name | JXHS2500077 | Import | 2025/07/23 | Bayer HealthCare Pharmaceuticals Inc.; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Gadoxetic Acid Disodium Injection | JYHB2500376 | Supplement | 2025/07/18 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2500202 | Supplement | 2025/04/07 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2500201 | Supplement | 2025/04/07 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2500200 | Supplement | 2025/04/07 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2500199 | Supplement | 2025/04/07 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2500198 | Supplement | 2025/04/07 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHB2500197 | Supplement | 2025/04/07 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2500126 | Supplement | 2025/03/10 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2500125 | Supplement | 2025/03/10 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2500124 | Supplement | 2025/03/10 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2500121 | Supplement | 2025/03/10 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadoxetic Acid Disodium Injection | JYHB2500063 | Supplement | 2025/02/09 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2400258 | Supplement | 2024/06/01 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2400257 | Supplement | 2024/06/01 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadoxetic Acid Disodium Injection | JYHZ2300322 | Import re-registration | 2023/08/02 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Gadoxetic Acid Disodium Injection | JYHB2300366 | Supplement | 2023/07/04 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHZ2200313 | Import re-registration | 2022/11/16 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Gadobutrol Injection | JYHZ2200312 | Import re-registration | 2022/11/16 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Gadobutrol Injection | JYHZ2200311 | Import re-registration | 2022/11/16 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Gadobutrol Injection | JYHZ2200310 | Import re-registration | 2022/11/16 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Gadobutrol Injection | JYHB2200595 | Supplement | 2022/11/02 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2200594 | Supplement | 2022/11/02 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2200593 | Supplement | 2022/11/02 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadobutrol Injection | JYHB2200592 | Supplement | 2022/11/02 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Clotrimazole Vaginal Tablets | JYHZ2200209 | Import re-registration | 2022/07/27 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Clotrimazole Vaginal Tablets | JYHZ2200208 | Import re-registration | 2022/07/27 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200052 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200051 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200050 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200049 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200048 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200047 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200046 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200045 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200044 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200043 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200042 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200041 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200040 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHZ2200039 | Import re-registration | 2022/02/25 | Bayer Vital GmbH; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Iopromide Injection | JYHB2200031 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2200030 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2200029 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2200028 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2200027 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2200026 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Iopromide Injection | JYHB2200025 | Supplement | 2022/01/17 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Ciprofloxacin Lactate and Sodium Chloride Injection | JYHZ2200012 | Import re-registration | 2022/01/14 | Bayer Vital GmbH; Bayer AG; Name not romanized | CDE ↗ |
| Ciprofloxacin Lactate and Sodium Chloride Injection | JYHZ2200011 | Import re-registration | 2022/01/14 | Bayer Vital GmbH; Bayer AG; Name not romanized | CDE ↗ |
| Clotrimazole Vaginal Tablets | JYHB2101634 | Supplement | 2021/12/31 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Aspirin Enteric-coated Tablets | JYHB2101474 | Supplement | 2021/10/21 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Aspirin Enteric-coated Tablets | JYHB2101473 | Supplement | 2021/10/21 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| Gadoxetic Acid Disodium Injection | JYHB2101394 | Supplement | 2021/09/08 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| No verified English name | JXHS2101025 | Import | 2021/07/09 | Bayer HealthCare Pharmaceuticals Inc.; Bayer AG; Bayer Healthcare Company Ltd. | CDE ↗ |
| Ciprofloxacin Lactate and Sodium Chloride Injection | JYHB2101102 | Supplement | 2021/05/19 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
| No verified English name | JXHS2100032 | Import | 2021/03/10 | Bayer HealthCare Pharmaceuticals Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2100037 | Import re-registration | 2021/02/27 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2100036 | Import re-registration | 2021/02/27 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2100035 | Import re-registration | 2021/02/27 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2100034 | Import re-registration | 2021/02/27 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2100033 | Import re-registration | 2021/02/27 | Bayer Inc.; Bayer AG | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | JYHZ2100032 | Import re-registration | 2021/02/27 | Bayer Inc.; Bayer AG | CDE ↗ |
| No verified English name | JTH2100023 | Not stated by source | 2021/01/25 | Penn Pharmaceutical Services Ltd.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100022 | Not stated by source | 2021/01/25 | Penn Pharmaceutical Services Ltd.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2100021 | Not stated by source | 2021/01/25 | Penn Pharmaceutical Services Ltd.; Bayer AG; Bai Er Pharmaceuticals Healthcare Co., Ltd. romanized | CDE ↗ |
| Iopromide Injection | JYHB2100084 | Supplement | 2021/01/21 | Bayer Vital GmbH; Bayer AG | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.